Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase II Trial of Alpelisib With iNOS Inhibitor and Nab-paclitaxel in Patients With HER2 Negative Metastatic or Locally Advanced Metaplastic Breast Cancer (MpBC)

This is a research study to test the safety and effectiveness of using the drug alpelisib together with chemotherapy (nab-paclitaxel) and a drug called L-NMMA …

HER2-negative Breast CancerMetastatic Breast CancerMetaplastic Breast Carcinoma+1 more

The Methodist Hospital Research InstituteNCT05660083